Clinical Trials Logo

Clinical Trial Summary

ABSTRACT Aim: Our study aimed to determine the approaches of our physicians to the smoking habits of their patients other than those with pulmonary diseases. Method: Patients examined in different outpatient clinics of our hospital will be asked 7 questions about the doctor's approach to smoking habits. 1) Do you have information about smoking cessation clinic? 2) Has your doctor asked if you smoke? 3) Did he suggest you stop using it? 4) Did he inform you about the relationship between smoking and your disease? 5) Did he provide information about smoking cessation outpatient clinic services? 6) Have you ever thought about quitting smoking after your doctor's briefing? 7) Did you quit smoking after your doctor's briefing?


Clinical Trial Description

1. INTRODUCTION: Tobacco use can cause many health problems with both its direct effects on all systems and passive smoke exposure (1). Tobacco use is very common in the world and ranks second among the most common causes of death. According to the World Health Organization, 20.2% of people aged 15 and over smoke and more than 8 million people die each year from active smoking. The mortality rates due to passive smoking are too high to be underestimated, and approximately 1.2 million people are lost due to health problems and second-hand smoke exposure (2). The prevalence of tobacco use among adults (aged 15 and over) is 31.2% (48% in men and 15% in women). Regular smoking is especially common between the ages of 25-44. Studies show that smoking rates in Turkey are inversely proportional to the level of education (3). Physicians are the most influential ones on tobacco use behavior. Informing patients about tobacco addiction, helping with treatment, and drawing a sample profile by not using tobacco is a profile that every physician should portray. Today, smoking cessation support is provided by specialist physicians (Chest diseases, Family medicine) to help smokers quit. In this process, patients are supported with both behavioral treatment and medical treatment (4-5). However, this support should not be limited to the specified sections. The physician evaluating a patient should contribute to tobacco control regardless of his/her branch, learn whether the patient is using tobacco or not, advise the patient to quit if he/she is using it, and should inform and direct the patient from smoking cessation outpatient clinics. In this study, it is aimed to evaluate the attitudes and habits of our physicians working in non-chest disease departments in our hospital and to determine their role in developing a positive attitude towards patients. With the results of the study, it is aimed to question the smoking habits of physicians in patients, to be a guide and leader, to reveal the differences in physician approaches according to branches, to be a guide for initiatives to increase positive attitudes by analyzing positive and negative results and self-criticism. 2. MATERIALS-METHODS: The study will start after the approval of the faculty ethics committee. Patients who were examined in other branch outpatient clinics other than the chest diseases department of our hospital will questioned for 3 months. Those who did not volunteer to participate in the survey, patients under the age of 18, and patients whose mental status was not suitable for the survey will not included in the study. As the place where the questionnaire will be conducted, the blood collection laboratory where all the patients come mostly was chosen, and the patients who came here to donate blood were randomly selected and the questionnaire was conducted. In addition to their demographic characteristics, the following 7 questions were asked to the patients. 1) Do you know about smoking cessation outpatient clinic? 2) Has your doctor asked if you smoke? 3) Has he suggested you stop using it? 4) Has he informed you about the relationship of smoking with your illness? 5) Has s/he informed about smoking cessation outpatient clinic services? 6) Have you ever considered quitting smoking after your doctor's briefings? 7) Have you quitted smoking after your doctor's briefings? The responses will compared according to the branches. It will investigated whether the patients asked the questions specified in the data form about their demographic characteristics, educational status, diagnosis, the branch they were examined in, the recommendations of the examining physician regarding the patient's smoking habit and whether they quit if they smoked. 2.1.Statistical Analysis The suitability of the data for normal distribution will examined with the ShapiroWilk and Kolmogorog Smirnov tests. Kruskall-Wallis, Mann-Whitney U, student-t and chi-square tests will used for intergroup comparisons. General linner modeling, Wilcowon and Friedman tests will used in serial follow-up data. Data will presented as percentage, mean (std deviation) and median (minimum-maximum). Pearson's chi-square test will used to compare the qualitative data. Categorical data will presented as frequency and percentage. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06163872
Study type Observational
Source Karadeniz Technical University
Contact
Status Completed
Phase
Start date May 1, 2023
Completion date September 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05176418 - IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate Early Phase 1
Completed NCT04084210 - Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use Phase 2
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Withdrawn NCT03707600 - State and Trait Mediated Response to TMS in Substance Use Disorder N/A
Recruiting NCT03999099 - Targeting Orexin to Treat Nicotine Dependence Phase 1
Completed NCT03847155 - Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery N/A
Completed NCT02840435 - Study on Sit to Quit Phone Intervention N/A
Completed NCT02139930 - Project 2: Strategies for Reducing Nicotine Content in Cigarettes N/A
Completed NCT01926626 - Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers Phase 2
Completed NCT01982110 - A Mindfulness Based Application for Smoking Cessation N/A
Completed NCT01632189 - The Effect of Varenicline on D2/D3 Receptor Binding in Smokers N/A
Withdrawn NCT01569477 - Striving to Quit-Wisconsin Tobacco Quit Line N/A
Completed NCT01569490 - Striving to Quit: First Breath N/A
Completed NCT01685996 - Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation Phase 1/Phase 2
Active, not recruiting NCT01182766 - New Treatment for Alcohol and Nicotine Dependence Phase 2/Phase 3
Completed NCT01061528 - Coping Skills Treatment for Smoking Cessation N/A
Completed NCT00996034 - Nicotine Vaccination and Nicotinic Receptor Occupancy Phase 2
Completed NCT01943994 - Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study N/A
Withdrawn NCT01589081 - Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect N/A
Suspended NCT01636336 - Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects N/A